Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-735-5 | CAS number: 371-40-4
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Referenceopen allclose all
- Reference Type:
- review article or handbook
- Title:
- Reaxys ID : 742030
- Year:
- 2 011
- Bibliographic source:
- Reaxys by Elsevier Properties SA; Okazaki, Yoshimasa; Yamashita, Kotaro; Ishii, Hiroyuki; Sudo, Masato; Tsuchitani, Minoru; Journal of Applied Toxicology; vol. 23; nb. 5; (2003); p. 315 - 322
- Reference Type:
- review article or handbook
- Title:
- RTECS Number: BY1575000
- Year:
- 2 012
- Bibliographic source:
- RTECS (Registry of Toxic Effects of Chemical Substances):- Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- Volume(issue)/page/year: 23,315,2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- Standard acute method
- GLP compliance:
- not specified
- Test type:
- standard acute method
Test material
- Reference substance name:
- 4-fluoroaniline
- EC Number:
- 206-735-5
- EC Name:
- 4-fluoroaniline
- Cas Number:
- 371-40-4
- Molecular formula:
- C6H6FN
- IUPAC Name:
- 4-fluoroaniline
- Details on test material:
- - Name of test material: 4-fluoroaniline
- Molecular formula: C6H6FN
- Molecular weight: 111.12
- Substance type: Organic
- Physical state: Liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
Administration / exposure
- Route of administration:
- other: peroral
- Vehicle:
- olive oil
- Doses:
- 100 - 1000 mg/kg
- No. of animals per sex per dose:
- no data
- Control animals:
- not specified
- Details on study design:
- Rats were treated with title compound; body weights recorded on days 2, 4, 8, 15, 16 post-dose; mortality and clinical signs observed at 30 min and 5 h after dosing and once a day for following 15 days
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- other: TDLo
- Effect level:
- 600 mg/kg bw
- Based on:
- dissolved
- Remarks on result:
- other: Other details not available
- Clinical signs:
- other: Spinal Cord - other degenerative changes Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage); recording from peripheral motor nerve; structural change in nerve or sheath Behavioral - alteration of class
- Other findings:
- Rats treated with 4-fluoroaniline showed cyanosis between days 1 and 4 and irregular respiration on day 1; mean body weights of treated rats
decreased on day 2 and were significantly lower than those of control on days 4, 8, 15 and 16
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Oral toxicity (TDLo) of 4-fluoroaniline to rat was examined at dose concentration of 600 mg/kg of body weight.
- Executive summary:
The potential for neurotoxicity after a single oral dose of 4-fluoroaniline (4-FA), given to rats, was investigated at or near the lethal dosage level. Hindlimb paralysis was found clinical observation, with the maximum incidence of 100% in 4-FA groups.
Oral toxicity (TDLo) of 4-fluoroaniline to rat was examined at dose concentration of 600 mg/kg of body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
